The University of Oxford announced on Monday the launch of a trial to deliberately reinfect people who already have Covid-19.Well-controlled research The type of immune response provided by volunteers will be analyzed.
Scientists will know When the second infection occurred and how many viruses were infectedVaccination professor Helen McShane said in a statement. Science alert.
Anyone with symptoms will receive the Regeneron antibody treatment used to treat Covid-19 patients.The first batch of exams at Oxford University were funded by the following institutions Wellcome Trust.
At the beginning of the trial, up to 64 healthy and healthy volunteers Between 18 and 30 years old They will be deliberately infected with the original Wuhan virus strain.
They will be isolated for at least 17 days in a special ward with lung and heart scanners.Then they will make follow-up appointments and They will be monitored for one year.
He said: “This research has the potential to change our understanding by providing high-quality data.” Shobana Balasingam, Senior Consultant of Wellcome Vaccine Research.
The initial phase of the trial will consider the minimum dose for the virus to begin to replicate without symptoms. 50% of volunteers. Then, in the second phase, another group of volunteers will receive this established minimum dose.
The test happens on London Hospital For the first time in the world, a group of healthy volunteers were quarantined while exposing them to the virus. This work started in March and is currently being carried out in collaboration with hVIVO at Imperial College London and Royal London Hospital.
Those ever Infected in a controlled manner Monitor it to see how the disease is progressing and how drugs and vaccines fight the disease.